The DOI matches its Crossref record; 109 of the 110 references it cites were found in a registry or an index.
Effectiveness of Opioids in the Treatment of Chronic Non-Cancer Pain
Open accessAbstract
For thousands of years, opioids have been used to treat pain, and they continue to be one of the most commonly prescribed medications for pain. It is estimated that 90% of patients presenting to pain centers and receiving treatment in such facilities are on opioids. Opioids can be considered broad-spectrum analgesics that act at multiple points along the pain pathway. Unfortunately, opioids also have the potential for great harm, with multiple side effects and potential complications, some of which are lethal. They are also uniquely addictive, which can lead to misuse and diversion. We reviewed the relevant English literature and did thorough manual searches of the bibliographies of known primary and review articles. We utilized pain relief as the primary outcome measure. Other outcome measures were functional improvement, improvement of psychological status, improvement in work status, and evidence of addiction. Short-term use and improvement was defined as less than 6 months and long-term relief was defined as 6 months or longer. The 3 systematic reviews evaluating long-term effectiveness of opioids for chronic non-cancer pain provided unclear and weak evidence. The results of this review showed that many patients in the included studies were dissatisfied with adverse events or insufficient pain relief from opioids and withdrew from the studies. For patients able to continue on opioids, evidence was weak suggesting that their pain scores were lower than before therapy and that this relief could be maintained long-term (> 6 months). There was also weak evidence that long-term opioid therapy with morphine and transdermal fentanyl not only decreases pain but also improves functioning. Limited evidence was available for the most commonly used opioids, oxycodone and hydrocodone. Evidence for the ability to drive on chronic opioid therapy was moderate without major side effects or complications. It is concluded that, for long-term opioid therapy of 6 months or longer in managing chronic non-cancer pain, with improvement in function and reduction in pain, there is weak evidence for morphine and transdermal fentanyl. However, there is limited or lack of evidence for all other controlled substances, including the most commonly used drugs, oxycodone and hydrocodone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The list of adverse symptoms included the most frequent side effects of treatments for pain [52,57,58].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Centers for Disease Control and Prevention
Branum, A. (2007) · Sage eBooks · doi:10.4135/9781412952644.n74 · Cited by 6,434
Anaesthesia, surgery, and challenges in postoperative recovery
Kehlet, H., & Dahl, J. B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14966-5 · Cited by 1,449
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,080
Opioid Therapy for Chronic Pain
Ballantyne, J. C., & Mao, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra025411 · Cited by 960
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 894
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Martell, B. A., O’Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00006 · Cited by 773
Increasing deaths from opioid analgesics in the United States
Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1276 · Cited by 696
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s63 · Cited by 638
Research works printed but not linked: 12
- Carr DB, Goudas LC. Acute pain. Lancet 1999; 353:2051-2058.
- Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC, Fellows B. Prev- alence of prescription drug abuse and dependency in patients with chronic An evaluation of multiple variables. Pain Physician 2006; 9:215-226.
- Deyo RA, Bass JE, Walsh NE, Schoenfeld LS, Ramamurthy S. Prognostic variabil- ity among chronic pain patients: Impli- cations for study design, interpreta- tion, and reporting. Arch Phys Med Re- habil 1988; 69:174-178.
- Mahmud MA, Webster BS, Courtney TK, pain in western Kentucky. J KY Med As- soc 2003; 101:511-517.
- Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of il- licit drug use in patients without con- trolled substance abuse in interven- tional pain management. Pain Physi- cian 2003; 6:173-178.
- Vaglienti RM, Huber SJ, Noel KR, John- stone RE. Misuse of prescribed con- trolled substances defined by urinaly- sis. W V Med J 2003; 99:67-70.
- Bouckoms A, Masand P, Murray G, Cas- sem E, Stern T, Tesar G. Chronic nonma- lignant pain treatment with long-term analgesics. Ann Clin Psychiatry 1992; 4:185-192.
- Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low back pain (review). Cochrane Data- base Syst Rev 2007; 3:CD004959.
- Sandoval JA, Furlan AD, Mailis-Gagnon AM. Oral methadone for chronic non- cancer pain; A systemic literature re- view of reasons for administration, pre- scription patterns, effectiveness, and side effects. Clin J Pain 2005; 21:503- 512.
- Mercadante S. Opioid rotation for can- cer pain: Rationale and clinical aspects. Cancer 1999; 86:1856-1866.
- Harden RN. Chronic opioid therapy: An- other reappraisal. APS Bulletin 2002; 12:1,8-12.
- Maier C, Schaub C, Willweber-Strumpf A, Zenz M. Long-term efficacy of opi- oid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment. Schmerz 2005; 19:410-417.
Cited by
Sorted by citations
Comprehensive Review of Epidemiology, Scope, and Impact of Spinal Pain
Manchikanti, L. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/e35 · Cited by 712
Breivik, H., Eisenberg, E., & O’Brien, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1229 · Cited by 643
Opioids and the treatment of chronic pain: Controversies, current status, and future directions.
Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013628 · Cited by 648
Therapeutic Use, Abuse, and Nonmedical Use of Opioids: A Ten-Year Perspective
Manchikanti, L. (2010) · Pain Physician · doi:10.36076/ppj.2010/13/401 · Cited by 535
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s5 · Cited by 430
Metadata
- Authors
- Trescot, A. M.
- Affiliations
- University of Florida (US)
- Corresponding author
- Trescot, Andrea M.
- ORCID
- Trescot, Andrea M.
- Venue
- Pain Physician
- Published
- 2008-03-14
- Volume
- 2s;11
- Issue
- 3;2s
- Pages
- S181-S200
- ISSN
- 1533-3159 (ISSN-L)
- 2150-1149
- OpenAlex
- W2176833613
- Cited by
- 169
- References
- 110
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 10 · 2021: 5 · 2020: 2 · 2019: 5 · 2018: 13 · 2017: 7 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 14 · 2012: 18
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pain Physician (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioids, chronic non-cancer pain, long-term opioid therapy, morphine, transdermal fentanyl, oxycodone, hydrocodone, analgesia, functional improvement, opioid side effects, opioid use disorder, controlled substances
- MeSH terms
- Analgesics, Opioid, Drug Administration Schedule, Fentanyl, Humans, Methadone, Morphine, Oxycodone, Oxymorphone, Pain, Quality of Life, Time Factors, Tramadol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
